Sucampo Pharmaceuticals Inc (SCMP) financial statements (2022 and earlier)

Company profile

Business Address 805 KING FARM BOULEVARD, SUITE 550
ROCKVILLE, MD 20850
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments198,308108,28494,01560,10558,057
Cash and cash equivalents198,308108,28471,62244,10252,022
Short-term investments  22,39316,0036,035
Restricted cash and investments21355,218213  
Receivables69,25945,55123,9145,4071,360
Inventory, net of allowances, customer advances and progress billings23,46833,121 209
Inventory23,46833,121 209 
Deferred costs17295295673673
Prepaid expense and other current assets1,930
Deferred tax assets  4762,028 
Other undisclosed current assets15,9678,8913,41144,93130,894
Total current assets:307,232251,360122,324113,35392,914
Noncurrent Assets
Inventory, Noncurrent    85
Property, plant and equipment6,2166,3937631,1561,540
Long-term investments and receivables5,495 13,5407,21914,408
Long-term investments5,495 13,5407,21914,408
Intangible assets, net (including goodwill)201,156197,4231516,4387,415
Goodwill73,02260,937   
Intangible assets, net (excluding goodwill)128,134136,4861516,4387,415
Restricted cash and investments  2,2242,4713,832
Deferred costs621,4001,6954,5405,213
Other noncurrent assets690605306584
Prepaid expense and other noncurrent assets820
Deferred tax assets, net  5711,212 
Other undisclosed noncurrent assets    1,569
Total noncurrent assets:213,619205,82119,25023,62034,882
TOTAL ASSETS:520,851457,181141,574136,973127,796
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28,73228,60617,36016,52817,458
Accounts payable9,19011,2134,1437,6145,496
Accrued liabilities12,38910,8868,4675,68210,595
Employee-related liabilities  3,4592,5311,219
Taxes payable7,1536,5071,291701148
Debt 39,0838,24026,89219,129
Deferred revenue and credits1,3156762,0511,3653,700
Other liabilities2,30414,1393,6183581,003
Other undisclosed current liabilities 5,6232,541(2,531)(1,219)
Total current liabilities:32,35188,12733,81042,61240,071
Noncurrent Liabilities
Long-term debt and lease obligation290,516213,27717,57825,82833,722
Long-term debt, excluding current maturities290,516213,27717,57825,82833,722
Liabilities, other than long-term debt30,88569,3289,23110,98111,381
Deferred revenue and credits8051,0885,4986,7657,501
Deferred tax liabilities, net21,28952,4978202,0662,627
Liability, pension and other postretirement and postemployment benefits  977
Other liabilities8,79115,7431,9362,1501,253
Other undisclosed noncurrent liabilities  (1,357)(596)(408)
Total noncurrent liabilities:321,401282,60525,45236,21344,695
Total liabilities:353,752370,73259,26278,82584,766
Stockholders' equity
Stockholders' equity attributable to parent, including:167,09986,44982,31258,14843,030
Treasury stock, value(46,269)(46,269)(2,313)(2,313)(1,977)
Additional paid in capital120,25199,21283,64672,10962,521
Accumulated other comprehensive income54,52713,41214,26515,60116,166
Retained earnings (accumulated deficit)38,12619,639(13,732)(27,681)(34,100)
Other undisclosed stockholders' equity attributable to parent464455446432420
Total stockholders' equity:167,09986,44982,31258,14843,030
TOTAL LIABILITIES AND EQUITY:520,851457,181141,574136,973127,796

Income statement (P&L) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues230,056153,180115,45089,59481,487
Revenue, net217,217142,981104,84469,17956,785
Cost of revenue(83,289)(36,731)(16,269)(12,402)(3,030)
Cost of goods and services sold(76,003)(36,731)(16,269)(12,402)(3,030)
Gross profit:146,767116,44999,18177,19278,457
Operating expenses(92,891)(71,990)(73,040)(69,484)(71,628)
Other operating income (expense), net  45,42244,984(47,360)
Other undisclosed operating income (loss)  (44,332)(43,496)48,848
Operating income:53,87644,45927,2319,1968,317
Nonoperating income (expense)(39,501)(784)(98)1,151(565)
Investment income, nonoperating72181172124179
Foreign currency transaction gain, before tax  1,146  
Other nonoperating income (expense)(1,765)5,8891,2502,9211,602
Interest and debt expense(14,047)(6,854)(1,520)(1,894)(2,346)
Other undisclosed income from continuing operations before equity method investments, income taxes14,0476,8541,5201,8942,346
Income from continuing operations before income taxes:14,37543,67527,13310,3477,752
Income tax expense (benefit)4,112(10,304)(14,005)(3,928)(2,916)
Net income available to common stockholders, basic:18,48733,37113,1286,4194,836
Interest on convertible debt64    
Net income available to common stockholders, diluted:18,55133,37113,1286,4194,836

Comprehensive Income ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income:18,48733,37113,1286,4194,836
Other comprehensive income (loss) (114)624  
Comprehensive income:18,48733,25713,7526,4194,836
Other undisclosed comprehensive income (loss), net of tax, attributable to parent41,115(739)(1,960)(565)(1,688)
Comprehensive income, net of tax, attributable to parent:59,60232,51811,7925,8543,148

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: